Please provide your email address to receive an email when new articles are posted on . Patients with diabetes achieved shorter OS than those without diabetes. Other predictors of shorter survival ...
For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or nephrectomy, according to a study published online March 3 in Radiology. Johanne ...
Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular ...
The LITESPARK-022 study tested belzutifan, an oral small-molecule inhibitor of hypoxia-inducible factor-2α (HIF-2α) targeting angiogenesis, in combination with standard of care pembrolizumab as ...
MedPage Today on MSN
Adjuvant Belzutifan-Pembrolizumab Significantly Boosts DFS in Kidney Cancer
Combination cut risk of recurrence or death by 28% in patients at high risk of relapse ...
Hosted on MSN
Kidney removal side effects: Understanding post-surgery pain, recovery, and health risks
Kidney removal, medically known as a nephrectomy, is a major surgical procedure performed to treat kidney disease, cancer, or to enable a healthy individual to donate a kidney. While the operation can ...
The trial enrolled 1,841 patients and measured DFS, with safety, OS, and quality of life as secondary endpoints.
Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...
Part B of the Checkmate 914 trial showed no disease-free survival (DFS) benefit with adjuvant nivolumab monotherapy in patients with localized renal cell carcinoma (RCC) at high risk of recurrence ...
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results